Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alpine Immune Sciences, Inc. logo — Leading the Next Evolution of Immunotherapies

Alpine Immune Sciences, Inc.

Leading the Next Evolution of Immunotherapies

Founded 2015 United States Seattle, United States 99 employees Post Ipo Equity Total: $475.30M Biotechnology, Health Care

General Information

Company Name Alpine Immune Sciences, Inc.
Founded Year 2015
Location United States Seattle, United States +1
Founders / Decision Makers
Team member
Employees 99
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Alpine Immune Sciences, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is a leading player in the biotechnology and health care industries. Founded in 2015, the company has now become a part of Vertex Pharmaceuticals, a global biotechnology company with a focus on transformative medicines for individuals with serious diseases. Alpine Immune Sciences recently received a substantial $150.00M post-IPO equity investment on 06 November 2023, showcasing the interest and confidence of investors in the company's potential. As an analyst, the alignment with a powerhouse like Vertex Pharmaceuticals augurs well for Alpine Immune Sciences, signaling a promising trajectory in the development of next-generation immunotherapies. This strategic integration underlines the significance of Alpine Immune Sciences in the biotech sector as it continues to push boundaries in innovative medical solutions. For further information about Vertex, interested parties can visit https://www.vrtx.com/ and follow Vertex on LinkedIn at https://www.linkedin.com/company/vertex-pharmaceuticals/ for future updates.

Taxonomy: clinical-stage biopharmaceutical, immunotherapy, autoimmune diseases, inflammatory diseases, protein-based therapies, immune synapse targeting, drug development, patented scientific platform, ALPN-303, povetacicept, BAFF antagonist, APRIL antagonist, ALPN-101, acazicolcept, ICOS antagonist

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 06 Nov 2023
Post-IPO Equity •••••• - 20 Sep 2022
Post-IPO Equity •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		15 Sep 2021
Post-IPO Equity •••••• 4
Investor Investor Investor
•••• •••• 		24 Jul 2020
Post-IPO Equity •••••• 5
Investor Investor Investor Investor
•••• •••• 		16 Jan 2019

View All 7 Funding Rounds

Alpine Immune Sciences, Inc. Alternatives & Competitors

Alpine Immune Sciences, Inc. vs
Encysive Pharmaceuticals
Encysive Pharmaceuticals

Leading the fight against vascular and inflammatory diseases with groundbreaking synthetic and small...

Private Equity
Biotechnology, Pharmaceutical
Compare Alpine Immune Sciences, Inc. vs Encysive Pharmaceuticals
Alpine Immune Sciences, Inc. vs
Vertex
Vertex Singapore

Trade, Earn, Borrow- All in one DEX.

Seed
14 employees
Crypto, Platforms
Compare Alpine Immune Sciences, Inc. vs Vertex
Alpine Immune Sciences, Inc. vs
Biopharma-mea
Biopharma-mea United Arab Emirates

Improving Lives

78 employees
Health Care, Pharmaceutical
Also compare with: Alpine Immune Sciences, Inc. vs CRISPR Therapeutics CRISPR Therapeutics

FAQ About Alpine Immune Sciences, Inc.

Leading the Next Evolution of Immunotherapies
Alpine Immune Sciences, Inc. was founded in 2015.
Alpine Immune Sciences, Inc. is headquartered in Seattle, United States.
Alpine Immune Sciences, Inc. operates in the following industries: Biotechnology, Health Care.
Alpine Immune Sciences, Inc. has approximately 99 employees.
Alpine Immune Sciences, Inc. has completed 7 funding rounds, raising a total of $475.30M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Alpine Immune Sciences, Inc. include Encysive Pharmaceuticals, Vertex, Biopharma-mea, CRISPR Therapeutics, Arriva Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alpine Immune Sciences, Inc. and Encysive Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alpine Immune Sciences, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes